Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Opinions have changed on the management of rectal cancer with a complete clinical response to neoadjuvant chemoradiotherapy.

× No keyword cloud information.

3 in total

1. Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer: A Multicenter Comparative Cross-Sectional Study with Rectal Preservation as Supported by Surgeon.

Authors: Kwang-Seop Song; Sung Chan Park; Dae Kyung Sohn; Jae Hwan Oh; Min Jung Kim; Ji Won Park; Seung-Bum Ryoo; Seung-Yong Jeong; Kyu Joo Park; Heung-Kwon Oh; Duck-Woo Kim; Sung-Bum Kang
Journal: World J Surg Date: 2019-12 Impact factor: 3.352

2. Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.

Authors: T L Clarke; D A White; M E Osborne; A M Shaw; N J Smart; I R Daniels
Journal: Ann R Coll Surg Engl Date: 2017-05 Impact factor: 1.891

3. A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.

Authors: Nick J Battersby; Mit Dattani; Sheela Rao; David Cunningham; Diana Tait; Richard Adams; Brendan J Moran; Shelize Khakoo; Paris Tekkis; Shahnawaz Rasheed; Alex Mirnezami; Philip Quirke; Nicholas P West; Iris Nagtegaal; Irene Chong; Anguraj Sadanandam; Nicola Valeri; Karen Thomas; Michelle Frost; Gina Brown
Journal: Trials Date: 2017-08-29 Impact factor: 2.279

3 in total